Edition:
United States

Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

620.70INR
26 May 2017
Change (% chg)

Rs8.80 (+1.44%)
Prev Close
Rs611.90
Open
Rs612.40
Day's High
Rs628.75
Day's Low
Rs611.10
Volume
1,397,875
Avg. Vol
1,078,035
52-wk High
Rs994.00
52-wk Low
Rs607.45

Latest Key Developments (Source: Significant Developments)

Glenmark to initiate clinical study for GBR 1342
Monday, 15 May 2017 08:00am EDT 

May 15 (Reuters) - Glenmark Pharmaceuticals Ltd :Glenmark pharmaceuticals to initiate clinical study for gbr 1342, second investigational new drug from immuno-oncology portfolio.  Full Article

Glenmark Pharma gets ANDA approval for fenofibrate capsules
Sunday, 9 Apr 2017 11:18pm EDT 

Glenmark Pharmaceuticals Ltd :Receives ANDA approval for fenofibrate capsules.  Full Article

Glenmark Pharma gets tentative ANDA approval from USFDA for milnacipran hydrochloride tablets
Thursday, 30 Mar 2017 11:14pm EDT 

Glenmark Pharmaceuticals Ltd :Receives tentative ANDA approval for milnacipran hydrochloride tablets.  Full Article

Glenmark Pharmaceuticals reports positive results from phase 3 trial of gsp 301
Wednesday, 29 Mar 2017 10:28am EDT 

Glenmark Pharmaceuticals Ltd : Glenmark Pharmaceuticals reports positive results from a Phase 3 trial of GSP 301, Mometasone/Olopatadine fixed-dose combination nasal spray, in seasonal allergic rhinitis . In trial treatment with GSP 301 demonstrated statistically significant and clinically meaningful improvement from baseline .All investigational treatments administered in trial were well-tolerated.  Full Article

Glenmark Pharma gets ANDA approval from USFDA for clobetasol propionate ointment
Monday, 20 Mar 2017 11:38pm EDT 

Glenmark Pharmaceuticals Ltd :Says receives ANDA approval for clobetasol propionate ointment USP, 0.05%.  Full Article

Glenmark Pharma gets tentative FDA nod for fingolimod capsules
Monday, 20 Mar 2017 12:54am EDT 

Glenmark Pharmaceuticals Ltd :Says Glenmark Pharmaceuticals receives tentative ANDA approval for Fingolimod capsules, 0.5 mg.  Full Article

Glenmark Pharma says Ankleshwar plant gets EIR issued by USFDA
Tuesday, 14 Mar 2017 11:36pm EDT 

Glenmark Pharmaceuticals Ltd :Says Ankleshwar plant has received the EIR (Establishment Inspection Report) issued by the FDA.  Full Article

Glenmark Pharmaceuticals receives FDA clearance of IND for GSP 304
Tuesday, 7 Mar 2017 10:49am EST 

Glenmark Pharmaceuticals Ltd : Glenmark Pharmaceuticals receives FDA clearance of IND for GSP 304 .Plans to initiate clinical development with a Phase 2 study of GSP 304 in subjects with mild to moderate COPD.  Full Article

Glenmark Pharmaceuticals and Evestra announce partnership agreement for generic NuvaRing
Wednesday, 1 Mar 2017 01:58pm EST 

Glenmark Pharmaceuticals Inc USA: Glenmark Pharmaceuticals And Evestra, Inc. announce partnership agreement for generic NuvaRing . Glenmark Pharmaceuticals USA and Evestra, expect to file an Abbreviated New Drug Application in fiscal 2019 . Evestra will develop this product exclusively for Glenmark for U.S. Market .Has secured exclusive marketing and distribution rights for product, for U.S. Market.  Full Article

Glenmark Pharmaceuticals Dec-qtr consol profit more than doubles
Thursday, 2 Feb 2017 02:41am EST 

Glenmark Pharmaceuticals Ltd : Glenmark Pharmaceuticals Ltd - dec-quarter consol net profit 4.77 billion rupees . Glenmark Pharmaceuticals Ltd - dec-quarter consol net sales 24.63 billion rupees . Glenmark Pharmaceuticals Ltd says overall growth for the organization has been bolstered due to the strong performance by US formulation business. . Glenmark Pharmaceuticals Ltd - consol net profit in dec quarter last year was 1.96 billion rupees as per Ind-AS; consol net sales was 17.46 billion rupees .Glenmark Pharmaceuticals Ltd consensus forecast for dec-quarter consol profit was 3.33 billion rupees.  Full Article

More From Around the Web

BRIEF-Glenmark Pharma gets ANDA approval for olmesartan medoxomil tablets

* Says ‍glenmark Pharmaceuticals receives ANDA approval for olmesartan medoxomil tablets, 5 mg, 20 mg and 40 mg​